SUBMISSIONS

SUBMISSION DETAIL

Arzu GNTRK
 


Keywords:



A FATAL CASE OF IMMUNE THROMBOCYTOPENIA IN A COVID-19 PATIENT
 
Thrombocytopenia is one of the laboratory findings that can be observed in cases of COVID-19 infections. There are some hypothetical mechanisms related to thrombocytopenia in COVID-19 patients. In this case report, we would like to share a case in which the platelet count decreased to ten thousand, which was severe and resulted in mortality. A 63-year-old male patient was diagnosed with a covid infection on 03/04/2021 after the COVID-19 PCR test was positive because of fever, weakness, and cough complaints. The patient was hospitalized at the end of the first week. 8 L/min oxygen support with nasal oxygen cannula, 2x 80 mg prednisolone IV, 0.6 ml 1x1 LMWH, 2 g/day paracetamol, 40mg/pantoprazole, 2000 mg/day vitamin c, 1500 U/day vitamin d, 600 mg 2x1 acetylcysteine treatment was applied. While the other blood elements of the patient were within the normal range, the decreasing trend of platelets continued, platelet was measured as 10000 on the 25th day, petechiae and hemoptysis were observed. On the 28th day, the number of PLTs per day decreased to 31 000. Colistin and voriconazole treatments were started. The patient, who was hypotensive and desaturated, died on the 35th day. The development of thrombocytopenia in Covid 19 patients is a sign of serious illness. It can be more fatal, especially in patients over 65 years of age. If necessary, repeated doses of IVIG should not be avoided. ORCID NO: 0000-0002-1096-8699

Anahtar Kelimeler: COVID-19, thrombocytopenia, thrombocyte, mortality